Hemcheck Health Economic Analysis

 by Hemcheck

Input

pcs
%
%
min
EUR
EUR
EUR

Information


The analysis is not including all societal costs and the suffering that patients and relatives may experience as a result of the problems caused by hemolysed blood tests.

  • Based on measured sensitivity and specificity in our performance evaluation and a cutoff value for hemolysis of 50 mg/dL.
  • Based on that all blood samples are tested and all identified hemolysed samples can be replaced with blood samples free from hemolysis.
  • Based on estimation of cost for pre-analytical errors from S. F. Green, “The cost of poor blood specimen quality and errors in preanalytical processes,” Clin. Biochem., vol. 46, no. 13–14, pp. 1175–1179, Sep. 2013.
  • Based on a delay of 60 minutes for retake of blood samples due to hemolysis.

Results

Total reduced patient length of stay

55

Hemolysed blood samples discovered in time

1 311

Total cost savings per year with Helge*

105 463

Cost savings per test with Helge*

7.03

Potential cost savings with Helge

Total cost for hemolysis with and without Helge per year (EUR)